Maria Pinkerneil

454 total citations
9 papers, 384 citations indexed

About

Maria Pinkerneil is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Maria Pinkerneil has authored 9 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Maria Pinkerneil's work include Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (6 papers) and Peptidase Inhibition and Analysis (3 papers). Maria Pinkerneil is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Histone Deacetylase Inhibitors Research (6 papers) and Peptidase Inhibition and Analysis (3 papers). Maria Pinkerneil collaborates with scholars based in Germany, United Kingdom and Japan. Maria Pinkerneil's co-authors include Michèle J. Hoffmann, Wolfgang A. Schulz, Günter Niegisch, Hella Kohlhof, Akinori Sato, Jindřich Činátl, Martin Michaelis, Makoto Isono, René Deenen and Karl Köhrer and has published in prestigious journals such as International Journal of Molecular Sciences, Current Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Maria Pinkerneil

9 papers receiving 383 citations

Peers

Maria Pinkerneil

MB

ONCOL

SURGE

CR

PRM

Tianlin He China

Monica Mancino Italy

Sandra Baumgart Germany

Jintong Ji China

Winfried Alsdorf Germany

Glenda Scandura United Kingdom

Kaori Yuuki Japan

Dimitris C. Kanellis Denmark

Hong‐Beom Park South Korea

Tianlin He China

Maria Pinkerneil

160 ×0.5

MB

116 ×1.2

ONCOL

50 ×0.7

SURGE

85 ×1.5

CR

50 ×2.1

PRM

Citations per year, relative to Maria Pinkerneil Maria Pinkerneil (= 1×) peers Tianlin He

Countries citing papers authored by Maria Pinkerneil

Since Specialization

Citations

This map shows the geographic impact of Maria Pinkerneil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Pinkerneil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Pinkerneil more than expected).

Fields of papers citing papers by Maria Pinkerneil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Pinkerneil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Pinkerneil. The network helps show where Maria Pinkerneil may publish in the future.

Co-authorship network of co-authors of Maria Pinkerneil

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Pinkerneil. A scholar is included among the top collaborators of Maria Pinkerneil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Pinkerneil. Maria Pinkerneil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Schulz, Wolfgang A., et al.. (2018). Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines. Clinical Epigenetics. 10(1). 1–1. 58 indexed citations

2.

Pinkerneil, Maria, Michèle J. Hoffmann, Ananda Ayyappan Jaguva Vasudevan, et al.. (2018). Effects of novel HDAC inhibitors on urothelial carcinoma cells. Clinical Epigenetics. 10(1). 100–100. 68 indexed citations

3.

Wagner, Nicholas, et al.. (2017). Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells. International Journal of Molecular Sciences. 18(7). 1449–1449. 21 indexed citations

4.

Pinkerneil, Maria, Michèle J. Hoffmann, & Günter Niegisch. (2017). Epigenetic Treatment Options in Urothelial Carcinoma. Methods in molecular biology. 1655. 289–317. 3 indexed citations

5.

Isono, Makoto, Michèle J. Hoffmann, Maria Pinkerneil, et al.. (2017). Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. Journal of Experimental & Clinical Cancer Research. 36(1). 1–1. 74 indexed citations

6.

Pinkerneil, Maria, Michèle J. Hoffmann, Wolfgang A. Schulz, & Günter Niegisch. (2017). HDACs and HDAC Inhibitors in Urothelial Carcinoma – Perspectives for an Antineoplastic Treatment. Current Medicinal Chemistry. 24(37). 4151–4165. 22 indexed citations

7.

Pinkerneil, Maria, Michèle J. Hoffmann, Hella Kohlhof, Wolfgang A. Schulz, & Günter Niegisch. (2016). Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines. Targeted Oncology. 11(6). 783–798. 51 indexed citations

8.

Hoffmann, Michèle J., Margaretha A. Skowron, Maria Pinkerneil, et al.. (2016). The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors. Bladder Cancer. 2(4). 449–463. 38 indexed citations

9.

Pinkerneil, Maria, Michèle J. Hoffmann, René Deenen, et al.. (2016). Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms. Molecular Cancer Therapeutics. 15(2). 299–312. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact